Y Intercept Hong Kong Ltd lifted its holdings in shares of Owens & Minor, Inc. (NYSE:OMI – Free Report) by 125.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 582,747 shares of the company’s stock after purchasing an additional 324,100 shares during the period. Y Intercept Hong Kong Ltd owned about 0.75% of Owens & Minor worth $2,797,000 at the end of the most recent reporting period.
Several other institutional investors also recently added to or reduced their stakes in OMI. Farther Finance Advisors LLC raised its position in Owens & Minor by 3,154.9% in the third quarter. Farther Finance Advisors LLC now owns 5,273 shares of the company’s stock worth $25,000 after acquiring an additional 5,111 shares during the period. DekaBank Deutsche Girozentrale increased its stake in shares of Owens & Minor by 76.6% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock worth $28,000 after purchasing an additional 1,356 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Owens & Minor in the 2nd quarter worth approximately $56,000. Blue Trust Inc. raised its holdings in shares of Owens & Minor by 52.2% in the 2nd quarter. Blue Trust Inc. now owns 6,709 shares of the company’s stock worth $61,000 after purchasing an additional 2,302 shares during the period. Finally, Tower Research Capital LLC TRC lifted its stake in Owens & Minor by 281.0% in the second quarter. Tower Research Capital LLC TRC now owns 7,548 shares of the company’s stock valued at $69,000 after purchasing an additional 5,567 shares during the last quarter. Institutional investors own 98.04% of the company’s stock.
Owens & Minor Price Performance
The stock has a 50 day moving average of $2.81 and a two-hundred day moving average of $4.44. The company has a market capitalization of $223.92 million, a price-to-earnings ratio of -0.17 and a beta of 1.37. Owens & Minor, Inc. has a twelve month low of $2.38 and a twelve month high of $15.54.
Analysts Set New Price Targets
Several analysts have issued reports on the company. Zacks Research lowered Owens & Minor from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Weiss Ratings reissued a “sell (e+)” rating on shares of Owens & Minor in a report on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating and four have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus target price of $6.35.
Check Out Our Latest Analysis on OMI
Owens & Minor Company Profile
Owens & Minor, Inc is a global healthcare solutions company specializing in the distribution of medical and surgical supplies, as well as supply chain management services. The company partners with healthcare providers, manufacturers and group purchasing organizations to deliver critical products and customized logistics solutions across the continuum of care. Its offerings range from standard medical-surgical products to specialized clinical devices, all supported by technology-driven inventory management and consulting services aimed at optimizing operational efficiency for hospitals, ambulatory surgery centers and other care facilities.
Founded in 1882 and headquartered in Mechanicsville, Virginia, Owens & Minor has evolved from a regional pharmaceutical distributor into a leader in healthcare logistics.
Recommended Stories
- Five stocks we like better than Owens & Minor
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- The biggest scam in the history of gold markets is unwinding
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.
